Macrosomic Newborn and Glucose Level in Lean Pregnant Diabetes Mellitus Patients at Dr. Soetomo General Hospital Surabaya
Abstract
Background: Gestational diabetes mellitus, defined as glucose intolerance in variable degree with onset during pregnancy, is a risk factor for the development of fetal macrosomia, a newborn with the birthweight of more than 4000g. The objective of this study was to explore an association between glucose level in lean pregnant diabetes mellitus patients, resulting in babies and the incidence of macrosomia in Dr Soetomo General Hospital in Surabaya.
Methods: This was a retroprospective analytic study with a cross sectional design by using medical records at Dr. Soetomo General Hospital Surabaya, collected from January 2016 to December 2017. The correlation between fasting glucose level, 2-hour postprandial glucose and glucose level at the time of birth and weight of newborn was assessed.
Results: Controlled and uncontrolled fasting glucose level, 2-hour postprandial glucose level and glucose level at the time of birth of mother were not significantly associated with macrosomia newborns. Macrosomia newborn were born with gestational diabetes mellitus mothers compare with pregestational mellitus mothers.
Conclusions: There is no association between macrosomia with glucose level of lean gestational and pregestational diabetes mellitus, however, therapeutic approach such as physical exercise should be implemented to reduce effects of uncontrolled glucose level.
Keywords
Full Text:
PDFReferences
Purnamasari D, Waspadji S, Adam J, Rudijanto A, Tahapary D. Indonesian Clinical Practice Guidelines for Diabetes in Pregnancy. Journal of the ASEAN Federation of Endocrine Societies, 2013;28(1):9–13.
Cyganek K. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control. Endocrine 2017;55(2):447–55.
Najafian M, Cheraghi M. Occurrence of fetal macrosomia rate and its maternal and neonatal complications: a 5-year cohort study. ISRN Obstet Gynecol. 2012;2012:353791.
Guy MM, Yves II, Charles KM, Didier MN, Sandra YM, NgoyAurelie KK, et al. Effect of gestational diabetes mellitus on macrosomia infants. Int J Cur Res Rev. 2017; 9(4):41–5.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. Practice Bulletin No 173: fetal macrosomia. Obstet Gynecol. 2016; 128(5):e195–e209.
Gopinath B, Prasad SM, Jayarama N, Prabhakara K. Study of factors associated with poor glycemic control in Type-2 Diabetic patients. Global Journal of Medicine and Public Health. 2013;2(2):1–5.
Mueller NT, Mueller NJ, Odegaard AO, Gross MD, Koh WP, Yuan GM, et al. Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG. 2013;120(12):1483–9.
Nadir S, Jamil S, Hamid M. The prevalence of macrosomia in newborns and its association with maternal diabetes. J Med Sci.2015;23(1):3–6.
Eslamian L, Akbari S, Marsoosi V, Jamal A. Effect of different maternal metabolic characteristics on fetal growth in women with gestational diabetes mellitus. Iran J Reprod Med. 2013; 11(4):325–34.
Bianchi C, de Gennaro G, Romano M, Aragona M, Battini L, Del Prato S, et al. Pre-pregnancy obesity, gestational diabetes or gestational weight gain: which is the strongest predictor of pregnancy outcomes? Diabetes Res Clin Pract. 2018;144:286–93.
Ma X, Zhang T. The effect of blood glucose control on pregnancy outcomes in pregnant women with gestational diabetes mellitus. Int J Clin Exp Med. 2017;10(11):15510–5.
Kanda E, Matsuda Y, Makido Y, Matsui H. Risk factors associated with altered fetal growth in patients with pregestational diabetes mellitus. J Matern Fetal Neonatal Med. 2012; 25(8):1390–4.
DOI: https://doi.org/10.15850/amj.v5n4.1510
Article Metrics
Abstract view : 546 timesPDF - 292 times
This Journal indexed by
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats